Jefferies Upgrades Immunomedics (IMMU) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Immunomedics (IMMU) Misses Q3 EPS by 2c
May 4, 2016 6:36 PM EDTImmunomedics (NASDAQ: IMMU) reported Q3 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $2.13 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
... More


